identify a paternal contribution, providing essentially unequivocal evidence for maternal UPD7. This paper proposed four mechanisms for UPD (Fig. 3) , each of which has been proven to occur. The last model, "trisomy to pseudodisomy," changed the way we counseled patients with chorionic villus sampling evidence for trisomy whose subsequent amniocentesis or cord blood sampling revealed a "normal karyotype analysis."
In an editorial accompanying the original paper, Warburton 2 proclaimed that this was an intellectually interesting phe- H a r l a n d S a n d e r s A w a r d (Fig. 4 ) reviews more than 30 literature reports of matUPD7 and also reveals that genetic screening identified matUPD7 in 15% of Russell-Silver syndrome cases and 3% of idiopathic short stature! The latter represents a not uncommon presentation in a pediatric genetics clinic. To date, UPD has been described in 19 of the 23 chromosome pairs with an abnormal clinical phenotype due to imprinting having been clearly defined for 6 chromosomes: matUPD for chromosomes 7, 14, and 15; patUPD for chromosomes 6, 14, and 15. 4 Art's lab focused on genetic imprinting, particularly in relation to chromosome 15 and the Angelman/Prader-Willi syndrome region given that UPD represented a mechanism for these diseases. After identifying mutations in the UBE3A gene encoding E6-AP ubiquitin-protein ligase as the cause for Angelman syndrome, 5 remarkably they demonstrated tissue-specific imprinted expression of Ube3a 6 in hippocampal and Purkinje neurons of the mouse (Fig. 5) . These seminal studies clearly established an important role for epigenetics in human clinical phenotypes.
Art's efforts in educating all of us in human and medical genetics have been as far-reaching and impressive as the many research accomplishments. With close colleagues he has been intensely involved in editing The Metabolic and Molecular Bases of Inherited Disease 7 through 3 editions, each accompanied by a major expansion from 1-2, 2-3, and 3-4 volumes. The latest 8th edition (Fig. 6 ) contains over 5000 pages! Art has directed the NIH Clinical Genetics Training Program for more than 25 years; close to 100 physician/scientists have graduated under his leadership.
I want to relate one anecdotal story to give the audience a taste for Art's involvement in this clinical training program. While I was a clinical fellow, Markus Grompe and I were on service together for a few months and Art was our attending clinical geneticist for a portion of this time. When he would staff the consult and we would meet with the parents, Art would ask to see the family pedigree we had drawn and proceed to ask the parents questions regarding family history until he identified an error in our pedigree. He would then look up from over his glasses with bowed head directly at us and not say anything, but the implication was clear. We quickly learned to be compulsively accurate with each pedigree. The next time Art was our attending, we drew extensive five-and six-generation pedigrees with multiple family members. We thoroughly enjoyed the look on Art's face when he tested our pedigrees by asking the parents questions. It was an incredible learning experience and fun to have such a mentor available.
In closing I would like to read the citation for this year's Colonel Harland Sanders Awardee: "Whereas your original research delineated the mechanisms for UPD in human disease and the molecular basis of imprinting in disorders such as Angelman syndrome; and for training a generation of clinical geneticist through your writings and leadership in medical education." Fig. 4 Maternal UPD7 has been identified as a cause of Russell-Silver syndrome and of idiopathic short stature. 
